Mubadala Bio
-
Mubadala Bio launches first UAE-made hemodialysis solutions through Wellpharma
The launch includes eight hospital-grade hemodialysis concentrate solutions designed to support the treatment of patients living with kidney failure.
-
M42 collaborates with Mubadala Bio to strengthen UAE healthcare logistics through strategic supply
As part of the collaboration, GMSC will work directly with M42’s clinical and operational teams to enhance demand forecasting, improve procurement efficiency, and provide greater inventory visibility across facilities.
-
Mubadala Bio expands digital healthcare reach through Valeo Health partnership in UAE
Valeo Health will serve as Mubadala Bio’s exclusive online channel partner, making products from IDS’ longevity and wellness portfolio more widely available through digital platforms.
-
Mubadala Bio strengthens UAE drug security with local hormone therapy launch
The local production of dydrogesterone represents not only an important milestone for Mubadala Bio and Bioventure Healthcare but also a timely contribution to supporting women’s health throughout the country.
-
Mubadala Bio’s subsidiary secures prestigious EU Quality certification
EU GMP certification confirms that Bioventure Healthcare meets the European Union’s demanding requirements for pharmaceutical manufacturing.
-
Mubadala Bio’s Bioventure Healthcare opens high-capacity facility for oncology products
The newly constructed, purpose-built facility is designed to handle high potency drugs, including oncology and hormone products.